Form D · Biotechnology

Smart Health Diagnostics Co

Irvine, CA · CIK 0001974021

Offering snapshot reported Nov 29, 2024 · SEC filing

Reported sold
$300K
Offering amount: $10M
Investors reported
2
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Nov 15, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 29, 2024Initial$300,000No comparison2SEC filing
Sep 3, 2024Initial$1,300,000No comparison3SEC filing
Sep 3, 2024Initial$100,000No comparison1SEC filing
May 13, 2024Amendment$15,589,576$5,352,649vs Mar 4, 202464SEC filing
Mar 4, 2024Amendment$10,236,927$5,136,927vs Apr 20, 202354SEC filing
Apr 20, 2023Initial$5,100,000No comparison29SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-530736

Source: Form D, filed Nov 29, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gus Blass Director
Ken Bright Executive
Lawrence Dentice Director, Executive
Gary Fudge Director
Mitch Levine Director, Executive
Susie Lu Director, Executive
Darin Nelson Director
Matthew Nunez Director, Executive
Guy Pinkman Director
Padma Sundar Director
Lance White Executive
Yonghong Wu Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5151 California Avenue #150
Irvine, CA, 92617